Abstract The bovine immunodeficiency virus (BIV) is a lentivirus which is known to infect cattle worldwide.
Introduction
The bovine immunodeficiency virus (BIV) belongs to the lentivirus genus of the subfamily Orthoretrovirinae under Retroviridae family [50] . The members of Retroviridae family are characterized by the expression of a unique enzyme reverse transcriptase (RT). The RT enzyme facilitates the transcription of the RNA of the infectious virus to a complimentary DNA copy which is incorporated in the host's cell nucleus as a 'provirus'. The provirus remains latent for many years without doing any harm to the host. In presence of pre-disposing factors such as concurrent infection, stress or age, the provirus may get reactivated into infectious RNA virus and may initiate pathogenesis inside host. The BIV causes a persistent viral infection in cattle and buffalo. Infection with BIV has never been linked to a specific disease or clinically identifiable syndrome, but it has been associated with lymphadenopathy, lymphocytosis, central nervous system lesions, progressive weakness [22, 88] , decreased milk yield [60] , decreased lymphocytic blastogenic response [59] and bovine paraplegic syndrome [90] . Though enough experimental evidences are available to believe that BIV can cause immune dysfunction in animals making them vulnerable to secondary infections [22, 33, 59] , the significance of natural BIV infection to health of cattle has not been clearly established. Interestingly, a closely related bovine lentivirus-Jembrana disease virus (JDV) is known to cause acute disease in Bali cattle and can not be differentiated serologically with currently available immunodiagnostic methods [52] .
Presence of BIV infection among cattle and buffaloes in India has been reported on the basis of genomic [73] as well as serological detections [11] [12] [13] [14] . Several other countries have reported BIV infection in cattle viz.
Southwest USA [15] , Canada [60] , Germany [67] , Japan [47] , Italy [24] , Australia [19] , Korea [26] , Pakistan [62] , Brazil [63] and Zambia [64] . The non-pathogenic nature of BIV, despite its close genetic and antigenic similarity with pathogenic lentiviruses like JDV and human immunodeficiency virus (HIV), is an interesting feature which makes this virus a good model for lentiviral research especially for understanding the pathogenesis and evaluating methods for effective treatment and control of pathogenic lentiviruses [34, 36] . This review focuses on the biological and molecular properties of BIV and its role in animal health system.
Historical background
BIV was first isolated in 1969 in Lousiana, USA from a Holstein cow with clinical signs of mild persistent lymphocytosis, generalized hyperplasia of lymph nodes, central nervous system lesions, weakness, and emaciation [88] . Histological examination of the tissues from the dead animal revealed a generalized follicular hyperplasia of lymph nodes and perivascular cuffing of the brain. The isolated virus induced formation of syncytia in cell cultures and was structurally similar to maedi-visna virus, hence designated as 'bovine visna-like virus.' Because this bovine lentivirus was not considered as the causative agent of leukemia/lymphosarcoma, its biology went unstudied for nearly a decade and half after its initial discovery until HIV was discovered in 1983 [7] . Twenty years later, it was demonstrated that the bovine R-29 isolate was a lentivirus which was very similar to the human immunodeficiency virus [37] [38] [39] . BIV was named on the basis of its morphologic, serologic and genetic features similar to the HIV and simian immunodeficiency viruses (SIV). The other two retroviruses discovered were bovine syncytial virus, a foamy virus or spumavirus; and bovine leukemia virus (BLV), an oncovirus [57, 65] . Generation and characterization of infectious cDNA clones BIV106 and BIV127 derived from R-29 isolate [18, 35] led to extensive studies on molecular biology of BIV. Two additional BIV field strains, termed FL491 and FL112, were isolated which were associated with the development of leukocytosis [84] . However, most pathological, serological and molecular biology information has been obtained from studies with the original BIV R-29 isolate.
Relationship with other lentiviruses
Lentiviruses that share structural, genetic, biological and/or pathological properties include maedi-visna virus (MVV) in sheep, caprine arthritis-encephalitis virus (CAEV) in goats, equine infectious anemia virus (EIAV) in horses, JDV and BIV in cattle, feline immunodeficiency virus (FIV) in cats, SIV and HIV in primates. Lentiviruses, which are not oncogenic, induce slow, chronic and degenerative pathological changes in infected hosts, often associated with the development of immune-mediated lesions [32] . All lentiviruses infect monocyte/macrophage cells. Moreover, FIV, SIV and HIV infect T cells and, consequently, are mainly associated with clinical signs of immunodeficiency in the infected hosts [3, 25, 39, 53, 87] . In contrast to the other retroviruses, lentiviruses may replicate in non-dividing cells. In addition, the lentivirus genome offers a complex structure including several regulatory/accessory genes that encode proteins, some of which are involved in the regulation of virus gene expression. HIV, the causative agent of the human acquired immune deficiency syndrome (AIDS), is the most studied lentivirus. Other lentiviruses, including BIV, may constitute alternative surrogate animal models for certain aspects of HIV research. The serological relationship of BIV with other lentiviruses (HIV-1, EIAV and SIV) has been studied in detail by Battles and co-workers [8] . In this study, it has been shown in Western blot analysis that BIV antiserum and capsid antigen cross-react with corresponding capsid antigen and anti-sera, respectively, for EIAV, SIV, and HIV-1. Amino acid alignment of the predicted sequence of capsid proteins of BIV, SIV, EIAV and HIV-1, revealed a highly conserved domain spanning 10 amino acids (p10). Through immunoprecipitation of HIV-1 p24 and BIV p26, p23 and p10 proteins with antiserum prepared against a 20 amino acid stretch in BIV capsid protein, it was shown that cross-reactivity among capsid proteins of BIV, HIV-1, EIAV and SIV is due to p10.
Genomic structure and function
BIV has the most complex genome organization among the lentiviruses with several regulatory genes involved in the regulation of the gene expression. Molecular cloning and sequencing of the proviruses from BIV-infected cells have been used to develop a complete genetic map of BIV [18, 35] . The deduced genetic complexity of BIV has been substantiated by Northen blotting and cDNA experiments used to characterize viral transcripts [56, 69, 70, 72] . Based on these experiments and the genetic map of BIV, Gonda et al. [41] described the genomic organization of BIV (Fig. 1a) . As per their description, the virus particle contains two copies of a single stranded RNA genome (dimer), similar to other retroviruses. The linear genome of BIV contains 8,960 base pairs in the form of proviral DNA which comprises of the obligatory retrovirus structural genes 'gag', 'pol' and 'env', flanked on the 5 0 and 3 0 ends by a complete copy of a long terminal repeat (LTR). The LTRs contain the promoters, enhancers and terminators of transcription. BIV also contains the complex lentivirus 'central region' between and overlapping the pol and env reading frames. The central region of BIV genome contains coding exons of several putative non-structural accessory genes including vif (viral infectivity factor), tat (transactivator of transcription), rev (regulator of virus expression), vpw, vpy and tmx. The products of the accessory genes 'vif' and 'Tat' as well as those of the structural genes 'gag' 'pol' and 'env' of BIV have some sequence similarity to their counterparts in HIV 1. However, the genomes of BIV and HIV-1 show overall divergence, with the 'gag' and 'pol' ORFs having the greatest sequence similarity.
The Tat protein is a non-structural regulatory protein of BIV. Tat gene of BIV encodes for Tat protein that basically enhances the level of viral RNA transcription. Two exons code for Tat protein, first is coded by an exon 5 0 of the envelop gene from nucleotides (nt) 5228 to 5536 and the second is encoded by an exon located within the envelop gene from nt 7657 to 7782. In a similar way, JDV-Tat is also coded by two exons i.e., exon Tat-1 and exon Tat-2. The sequences of Tat-2 were completely conserved than that of Tat-1 sequences [77] . JDV-Tat protein binds to BIV-TAR with higher affinity than BIV-Tat peptide itself [21] . A new BIV-Tat236 and long terminal repeats (LTRn) protein expressed by variant of BIV has been reported [29] . The variant BIV-LTRn has three nucleic acid mutations at positions -194, -135 and -114 upon comparison with the wild type BIV. Such LTRn promotes a higher Tat mediated trans-activation. The Tat protein of BIV, after expression in host cells, binds to a viral RNA stem loop structure called trans-activating response element (TAR) which is located at 5 0 ends of BIV transcripts. In association with positive transcription elongation factor (P-TEFb), Tat enhances the production of full length viral RNA [56] . It was also reported that BIV-Tat has a role in proapoptotic action of BIV in inducing apoptotic cell death which may be related in causing cytopathic effect in cell culture. BIV-Tat also regulates microtubule dynamics in host cells [95] . Internalization of BIV-Tat in infected cells helps BIV in influencing neighboring cells and makes the cellular environment conducive to viral replication [31] . Functions of BIV-Tat have been exploited for analysis of the TNRC6B protein, a component of the microRNA induced silencing complex in cell multiplication [89] . The knockdown of bovine hexamethylene bisacetamide (HMBA)- induced protein (BHEXIM1) enhances BIV replication and it competes with BIV-Tat by binding to B-cyclin T1 [45] . This information may help in understanding the BIV latent life cycle. The molecular research work on BIV-Tat-TAR is exploited towards either for up regulation or for inhibitory purpose of the HIV-1 TAR [5] .
BIV infection cycle
BIV infection cycle (Fig. 1b) has been described by Gonda and Oberste [40] . The BIV genome consists of two positivesense, single-stranded, protein-encapsidated RNA genomes. During the infection cycle, free BIV particles attach to specific cell surface receptors via the envelop glycoprotein of the virus. Subsequently, the viral envelop fuses with the plasma membrane releasing genomic RNA and mature pol gene products from the core of the virus into the cytoplasm. The viral RT transcribes the viral RNA into double-stranded DNA which is then transported to the nucleus where it is incorporated into the host genome with the help of integrase (IN) enzyme. The integrated provirus remains transcriptionally silent until appropriate cellular signals activate gene expression from the viral LTR. Cell-mediated expression from the viral LTR is significantly enhanced by the action of the virally coded Tat protein. Splicing of the primary genome-length viral mRNA into sub-genomic messages and transport to the cytoplasm is carried out by the cellular splicing machinery and another virally encoded protein, 'Rev' (regulator of virus expression). Sub-genomic mRNAs are translated on the ribosomes in the cytoplasm of the infected cell. Viral precursors for gag (group specific antigen) and gag-pol assemble beneath the plasma membrane and incorporate viral genomic RNA during the process of budding. The viral envelop is studded with surface (SU) and transmembrane (TM) glycoprotein. Following release, gag-related precursors in the immature particle are cleaved into their functional subunits by the viral protease (PR) as the virus undergoes morphogenesis into a mature infectious particle. The mature particle can begin the infection cycle again by binding to a naïve cell expressing the appropriate receptor for BIV.
Genetic diversity in BIV
Lentiviruses exhibit antigenic variations to evade immune surveillance and thereby replicate fast to produce more number of viruses. Genomic diversity in lentiviruses including BIV is attributed to mutations, recombination events and selective pressure that act on viruses during replication [17, 20, 58, 86] . Lentiviral persistency in host cells is another mechanism to survive for longer period. There are many reports on study of variation and selected stability in certain genomic regions of BIV during its life cycle. A limited genetic variation has been reported during long term persistency in host cells upon comparison of env sequences of BIV isolated at 4-5 years post infection [23] .
Genetic variation is reported largely in regions of pol and env sequences [30, 61, 81, 83, 85] . Suarez and co-workers [85] compared nucleotide sequences of RT region of pol gene of thirteen BIV isolates which were shown to have up to 10 and 11 % divergence in nucleotide and amino acid homology respectively. There was no size variation in the RT region of all isolates. The sequence variation in the RT gene region was found to be uniform [44, 54] . The conserved regions in the RT domain of pol gene have maintained the identity of BIV when it was diverging from HIV-1. The proportion of replacement substitutions remained same in the RT domain and about 85 % of the fixed replacement differences were critical in evolutionary development of the BIV. It has been hypothesized that the existence of BIV pol quasispecies is due to presence of nonconservative amino acid changes [30] .
Surface (SU) envelope protein is more prone for genetic variation and any change in this protein can alter the cell tropism [28, 74] . Size variation in the SU protein of BIV is a common phenomenon due to recombination events [81, 83] . Size variable viruses do have advantages in antigenicity and multiplicity of BIV [55] . A 5 % sequence divergence was observed upon comparison of SU gene sequences of R-29 and R-29 derived isolates. The sequence variations due to nine amino acid changes were found to be spread throughout the SU gene wherein seven of nine amino acid changes were in the conserved region. The conserved region of the SU gene was recognized as the region larger than 12 aa that had less than 10 % sequence divergence from the consensus. The hypervariable region was defined as the region larger than 12 aa with greater than 30 % sequence divergence from the consensus. Six conserved and hypervariable regions in SU genomic regions have been identified [66, 79] . Five conserved sites were identified in N-glycosylation sites of different BIV isolates. Large size differences of 104 nucleotides in SU gene were reported among BIV isolates being highest in V2, V4 and V6 hypervariable regions. Limited information on variations in other genomic regions of BIV is available. A hybrid Tat236 of Tat protein of BIV was characterized which contained the first 98 amino acids of Tat103 and 3 0 end 138 amino acids of Rev of BIV variant which had higher trans-activation properties [80] .
Pathogenesis of BIV
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in vivo [39] . The in vitro tropism of BIV is quite broad. BIV replicates in fibroblast like cells and is cytopathic in most, causing syncytia and cell death [41] . Productive infections have been established in primary cultures of embryonic bovine spleen, brain, lung, choroid plexus, testes, thymus, kidney, and synovial membrane [38] . In addition, established canine thymus (Cf2Th), embryonic rabbit epithelium (EREp) and various other bovine cell lines have been used for infecting the virus [36, 40, 42] . Only Cf2Th cell line is known to sustain a long-term productive infection [16, 36, 42] . In peripheral blood mononuclear cells (PBMC) collected from naturally infected animals, BIV has been shown to infect and transcribe its genome in different subsets of cells-CD3?, CD4?, CD8? and cd-T cells, B cells and monocytes [93, 94] . BIV is pathologically more related to lentiviruses that cause chronic inflammatory diseases (CAEV and EIAV) as compared to those that cause severe immunodeficiency (HIV, FIV and SIV). However, unlike CAEV and EIAV which are known to cause clinically identifiable disease in the susceptible hosts, it has not been clearly established whether natural infection of BIV causes any significant effect on health of cattle even though experimental evidences suggest that BIV can cause immune dysfunction and can predispose animals to secondary infections. Earliest evidence of BIV infection being cause of immunodeficiency in cattle comes from a long term study (more than 7 years) at Louisiana State University dairy herd which had high seroprevalence of BIV [78] and had high incidence of common diseases that reduced the economic viability of the dairy. The herd had a high percentage of cows with encephalitis associated with depression and stupor, alteration of the immune system associated with secondary bacterial infections, and chronic inflammatory lesions of the feet and legs. Histological examination of brain tissue from BIV-infected animals in this herd revealed a non-suppurative perivascular cuffing indicative of viral meningo-encephalitis. These central nervous system lesions were similar to those described earlier by Van Der Maaten et al. [88] and could not be attributed to other viral infections. Later on, studies were conducted by various groups to elucidate the pathogenesis of BIV in cattle. In several studies, experimental infection of calves with BIV R-29 isolates has demonstrated a transient lymphocytosis and lymphadenopathy without any overt clinical signs [22, 71, 84, 88] . Investigations on immune dysfunction have been carried out in animals experimentally infected with BIV. Onuma and co-workers [71] have shown that BIV infection of cattle reduces the responsiveness of various important monocyte functions without a change in CD4/CD8 ratios. Other studies examining the effect of BIV infection on immune function have demonstrated either mild or no immunosuppression on the basis of lymphocyte blastogenesis tests, neutrophil function tests, mononuclear subset analysis, and histopathological changes [22, 33, 59] . In another important study, Zhang and coworkers [96] observed a decrease in CD4/CD8 ratio and an overall increased lymphocyte proliferation 2-6 weeks postinfection in calves inoculated with BIV, suggesting a possible immune dysfunction in BIV-infected calves. The antibody response to BHV-1 and bovine viral diarrhea vaccine was significantly lower in BIV-infected calves than in uninfected controls.
Immune response to BIV in cattle
Humoral immune response A number of studies have characterized the humoral immune response to BIV in naturally as well as experimentally infected cattle. In one such significant study, virus-specific antibodies could be detected in calves inoculated with BIV R-29 strain as early as 2 weeks postinoculation (PI) and remained for about 2-2.5 years PI [92] . As detected by western blot, they have shown that first serum antibody response was against the p26 protein followed by gp110 (SU or surface part of envelop glycoprotein), p55 (gag-pol precursor polyprotein), gp42 (TM or transmembrane part of envelop glycoprotein), p18 (MA or matrix part of gag) and p13 (NC or nucleocapsid part of gag). Results from this study and other studies have shown that p26 is the most immunodominant protein of BIV and in experimentally infected calves antibodies to p26 can be detected as early as 2 weeks PI and can last for 2 years. However, the antibodies to p26 were observed decreasing after 1.5 years after experimental infection of animals by BIV. In contrast, antibodies to the env-encoded TM protein appeared later than p26 protein and persisted for more than 3.5 or 4 years in animals exposed to BIV [1, 2, 51] . It has also been shown that immune sera from animals infected with other bovine viruses like BVDV and BLV do not react with BIV p26 antigen in Western blot indicating the specificity of p26 for anti-BIV antibodies [99] . Due to specificity of p26, most of the serological tests for BIV like Western blotting, indirect fluorescent antibody technique (IFAT) and indirect ELISA have used this protein as antigen for detection of antibodies in cattle.
Cellular immune response
The cell-mediated immunity to BIV has not been studied in great detail. However, there are a number of studies on effect of BIV infection (natural or experimental) on T cell responses to mitogens and other viral agents. A significant increase in specific lymphocyte proliferation to BIV antigen (gag) was demonstrated in BIV-infected calves from 2 to 6 weeks post-infection (PI) while there was no increase in lymphocyte proliferation to mitogens and to BHV-1 and BVDV viral antigens. The CD4/CD8 ratio also declined during 2-7 weeks PI indicating a possible immune dysfunction in BIV infected calves [96] . The reduction of in vitro lymphoproliferative responses to specific antigens or to mitogens (phytohemagglutinin, concanavalin A (Con A) and pokeweed mitogen) was demonstrated with mononuclear cells isolated from cattle [59] or sheep [47] experimentally exposed to BIV.
Diagnosis
Virus isolation
Virus isolation is considered as the 'gold standard' laboratory test for diagnosis of many viral pathogens. Isolation of BIV, especially from naturally infected animals, has been difficult and there have been only four successful isolations till date. The first reported isolation of BIV was from a cow with persistent lymphocytosis and was named as R-29 [88] . The other three were BIVCR1 from Costa Rica [46] and FL491 and FL112 from Florida, USA [84] . All the four isolates used co-cultivation techniques using PBMC from infected animal with either fetal bovine spleen cells, fetal bovine lung cells or embryonic rabbit embryonic cells [84] . Due to the difficulties in isolation, molecular and serological methods have been adopted routinely for diagnosis of BIV.
Molecular diagnosis
Diagnosis of BIV by PCR is considered a reliable method to detect infected cattle [82] . Sensitive PCR diagnostic methods have been developed for the detection of proviral BIV DNA in mononuclear cells [68, 85, 97] . A nested PCR targeting two separate regions of pol and env was developed and was found to have a greater sensitivity than serology and virus isolation [85] . However, it has been acknowledged by authors that there is no gold standard for BIV testing at present [83] . They reported that their env primers had the broadest specificity of all those tested, making them the most appropriate for the testing of field samples. In another study, the pol primers were found to be 30-to 100-fold more sensitive than the env primers and proved to be the most useful for BIV detection in the experimentally infected bulls [43] . In India, primers specific to gag region of BIV genome were used to detect BIV in blood samples and milk samples. Though, the sensitivity and specificity of this PCR was not estimated, all the positive samples (10) were found to be specific to BIV by semi-nested PCR and restriction analysis [73] .
Serological diagnosis
For serological studies, the R-29 isolate of BIV was used most widely as a source of antigen before the availability of recombinant BIV antigens till 1999 [4, 15, 27, 48, 49, 92] . It was speculated that the exclusive use of BIV R-29 antigen in serological screening may not detect the seropositivity in animals infected with serologically distinct BIV-variants [8, 35] . Use of recombinant viral proteins in place of native viral proteins facilitated to study sero-epidemiology of BIV infection [2, 10, 98] . Indirect ELISA based on recombinant capsid protein [98] or baculovirus-expressed transmembrane protein [1] have been in use for sero-diagnosis. The 'gag' gene of BIV has been cloned into a baculovirus expression system [76] and bacterial systems as fusion protein [6, 10, 98] . The bacterial part of the fusion protein in the TrPE system accounted for 50 % of the total, which created problem in ELISA [98] . The recombinant capsid protein has been used to perform Western blot and indirect ELISA for detection of serum antibodies against BIV [98] . Since then, many workers have used recombinant capsid protein of BIV as antigen for serological detection of BIV infection.
In India, a recombinant capsid (p26) protein based indirect ELISA was standardized to test sera of cattle and buffalo for carrying out sero-surveillance of BIV in India [11] . Production of monoclonal antibodies (MAbs) and recombinant antibodies against capsid protein has been reported from India [13, 14] . Elsewhere in the World, MAbs to BIV gag proteins have been developed and were found to react specifically with the BIV p26 and recombinant capsid protein in Western immunoblot assay and were found useful in detecting BIV replication in cell culture [91] . Competitive binding assays, using anti-capsid MAbs, demonstrated the existence of at least 3 distinct antigenic determinants on the capsid protein and one of the MAbs differentiated the capsid protein of JDV and BIV indicating that at least one epitope is unique in BIV capsid from JDV capsid [99] .
Sero-epidemiology of BIV
Sero-epidemiological data on BIV suggest that the presence of BIV infection is worldwide. Due to lack of BIV isolates and difficulties in producing large amount of BIV antigen, only few countries could under take serological screening of BIV till late 1990s. Later, development of recombinant BIV antigen facilitated the seroprevalence studies worldwide. Expression of BIV capsid p26 protein in bacterial system and use of recombinant p26 protein in Western blot provided an easier way to study sero-epidemiology of BIV infection [10] . After that, many European and Asian countries took up seroprevalence studies on BIV infection. Some of the important seroprevalence studies are described below.
Serologic screening of randomly selected cattle sera using R-29 as a source of antigen has shown a non-uniform distribution in the USA [4, 15, 27, 92] . From southern and south western part of USA approximately 4 % of cattle sera were positive [13] while cattle sera from eastern or north eastern part of USA were rarely positive [48] . A chemiluminiscence Western blot assay detected anti-BIV antibodies in sera of 5.5 % of 928 adult cows from Ontario [60] . In Germany, serum samples from 6.6 % of 380 cattle were positive for presence of anti-BIV antibodies by cell-ELISA and immunofluorescence assay [67] . In France, a recombinant 53 kDa BIV R-29 antigen was used which gave weaker reaction with French sera than with positives from Louisiana indicating the occurrence of distinct French and Louisiana BIV variant [75] . In Hokkaido, Japan, the seroprevalence of BIV up to 7.5 % in 120 cattle with relatively higher prevalence of BLV (Bovine Leukemia Virus) has been reported [47] . Apart from these reports, serological evidence of BIV infection has been reported from Italy [24] , Australia [19] , Korea [26] , Brazil [63] , Zambia [64] and Pakistan [62] .
Status of BIV infection in India
The status of BIV infection in Indian cattle was not known till the year 2000. The first evidence of BIV infection in cattle in India was reported in the year 2003 through detection of BIV through PCR [73] . The nucleotide sequence of three PCR amplicons (p26 region) matched with the reference strain (R-29) with 96-97 % homology. Later on, with development of recombinant capsid based ELISAs, seroprevalence studies were taken up to test large number of animals [11] [12] [13] [14] . Out of the 672 animals tested by capsid based indirect ELISA, 162 were positive and 510 were negative, giving an overall prevalence of 24 % in India [11] . In a subsequent study in India, a MAb based competitive inhibition ELISA showed much higher agreement (concordance-95.4 %) than the indirect ELISA (concordance-77.8 %) with western blot [13] . In a further study, a recombinant antibody as ScFv (Single chain Fragment variable) protein molecule was generated against the recombinant capsid protein of BIV and was shown to react specifically with the antigen. The anticapsid recombinant antibody was used in a competitive inhibition ELISA for detection of BIV antibodies and was found to be more sensitive than the MAb-based ELISA [14] . Looking at the international scenario and worldwide presence of BIV in cattle, it is no surprise that cattle in India are also carrying this infection. Though intermittent monitoring of BIV infection in cattle may be carried out to check any possible changes in the virus, continuous surveillance may not be required as BIV is not considered a serious threat to cattle health.
Conclusions
At present research on BIV is being carried out in two directions. First is the molecular biology study of the virus to unravel the role of various viral genes in regulation of its replication. Secondly, BIV infection in cattle is being studied for its possible role in causing immune dysfunction. Except few studies on effect of BIV infection on immune system, not much experimental work has been carried out in this field probably because of less number of virus isolates available in the world.
The basic studies on BIV are aimed at identifying the parts of the genome of BIV which differ from its more pathogenic but closely related lentiviruses such as HIV. Since there are no safety issues with BIV, it is also a good model for studying lentiviruses. Lentiviruses have the potential to be utilized in gene therapy as they can infect non-dividing cells. Thus far, the lentiviruses used have been primate viruses that may possess the potential to cause disease in humans. As a non-primate virus, BIV does not have this potential and so may represent a safer candidate for gene therapy. BIV has been found to transduce a variety of cells from a variety of organisms [9] . Thus BIV has the potential to be used as research tool and a good and safe model to study lentiviruses. While its role in cattle health does not seem to be serious, its presence in this host cannot be ignored and needs to be observed.
